title: Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.
abstract: In 35 patients with recurrent gastric cancer who had undergone curative gastrectomy, serum carcinoembryonic antigen (CEA) and CA 19-9 (carbohydrate antigen) tumor marker levels were investigated. At least one tumor marker was elevated in 24 (68.6%) patients. The levels of serum CA 19-9 and CEA markers were increased in 20 (57.1%) and 12 (34.3%) patients, respectively. This difference was not statistically significant. However, it may be important in terms of clinical practice.
authors.affiliation: Division of Medical Oncology, Institute of Oncology, University of Istanbul, Istanbul, Turkey.
authors.forename: F
authors.initials: F
authors.lastname: Tas
authors.forename: N
authors.initials: N
authors.lastname: Faruk Aykan
authors.forename: A
authors.initials: A
authors.lastname: Aydiner
authors.forename: V
authors.initials: V
authors.lastname: Yasasever
authors.forename: E
authors.initials: E
authors.lastname: Topuz
mesh_terms: D018395:CA-19-9 Antigen / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D005743:Gastrectomy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000097:blood* / Q000175:diagnosis; D013274:Stomach Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000601:surgery
chemical_list: D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen